ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
10.75
0.00
(0.00%)
Closed 26 January 8:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
10.75
Bid
10.53
Offer
10.60
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
10.75
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
7,990,000
Dividend Yield
-
PE Ratio
83.40
Earnings Per Share (EPS)
0.13
Revenue
-
Net Profit
1.03M

About Pender Growth Fund Inc

Sector
Investment Advice
Industry
Investment Advice
Headquarters
Vancouver, British Columbia, Can
Founded
-
Pender Growth Fund Inc is listed in the Investment Advice sector of the TSX Venture Exchange with ticker PTF. The last closing price for Pender Growth was $10.75. Over the last year, Pender Growth shares have traded in a share price range of $ 0.00 to $ 0.00.

Pender Growth currently has 7,990,000 shares in issue. The market capitalisation of Pender Growth is $85.89 million. Pender Growth has a price to earnings ratio (PE ratio) of 83.40.

PTF Latest News

Pender Growth Fund Provides Financial Highlights and Company Updates

VANCOUVER, British Columbia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (the “Company”) today announced its financial and operational results for the three months and...

Pender Growth Fund Announces Acquisition of Four Technology Companies from Pluribus Technologies

VANCOUVER, British Columbia, Oct. 11, 2024 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (“Pender” or the “Company”) is pleased to announce the completed acquisition of four technology...

Pender Growth Fund Provides Financial Highlights and Company Updates

VANCOUVER, British Columbia, Aug. 23, 2024 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (the “Company”) today announced its financial and operational results for the three months and...

Pender Growth Fund Portfolio Company Announces Proposed Transaction

VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (the “Company” or “PTF”) today announces that one of its significant investees, Copperleaf...

Pender Growth Fund Provides Financial Highlights and Company Updates

VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- (TSXV: PTF) -- Pender Growth Fund Inc. (the “Company”) today announced its financial and operational results for the three months...

Pender Growth Fund Provides Financial Highlights and Company Updates

VANCOUVER, British Columbia, April 05, 2024 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (the “Company”) today announced its financial and operational results for the year ended...

24/02/13 - TSX Venture Exchange Stock Maintenance Bulletins

24/02/13 - TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, Feb. 13, 2024 VANCOUVER, BC, Feb. 13, 2024 /CNW/ -TSX VENTURE COMPANIES BULLETIN V2024-0472 HIGH TIDE...

Pender Growth Fund Provides Notice of its Intention to Undertake Normal Course Issuer Bid

VANCOUVER, British Columbia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- (TSXV: PTF) Pender Growth Fund Inc. (the “Company”) announces that it has provided the TSX Venture Exchange (the "TSXV") with its...

Pender Growth Fund Provides Financial Highlights and Company Updates

VANCOUVER, British Columbia, Nov. 23, 2023 (GLOBE NEWSWIRE) -- Pender Growth Fund Inc. (the “Company”) today announced its financial and operational results for the three months and nine months...

Pender Growth Fund Inc. Appoints New Director to the Board

VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Pender Growth Fund Inc. (“PGF”; TSXV: PTF) is pleased to announce the addition of Derek Hemmes to its Board of Directors, with...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

PTF - Frequently Asked Questions (FAQ)

What is the current Pender Growth share price?
The current share price of Pender Growth is $ 10.75
How many Pender Growth shares are in issue?
Pender Growth has 7,990,000 shares in issue
What is the market cap of Pender Growth?
The market capitalisation of Pender Growth is CAD 85.89M
What is the 1 year trading range for Pender Growth share price?
Pender Growth has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Pender Growth?
The price to earnings ratio of Pender Growth is 83.4
What is the reporting currency for Pender Growth?
Pender Growth reports financial results in CAD
What is the latest annual profit for Pender Growth?
The latest annual profit of Pender Growth is CAD 1.03M
What is the registered address of Pender Growth?
The registered address for Pender Growth is SUITE 1830 - 1066 W. HASTINGS STREET, VANCOUVER, BRITISH COLUMBIA, V6E 3X2
What is the Pender Growth website address?
The website address for Pender Growth is www.pendergrowthfund.com
Which industry sector does Pender Growth operate in?
Pender Growth operates in the INVESTMENT ADVICE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ADEAdex Mining Inc
$ 0.01
(100.00%)
1,000
DEALPlaygon Games Inc
$ 0.02
(100.00%)
1.75M
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
15.6k
GBUGabriel Resources Ltd
$ 0.01
(100.00%)
167k
MACThemac Resources Group Ltd
$ 0.08
(60.00%)
3k
NAVNAVCO Pharmaceuticals Inc
$ 0.005
(-50.00%)
16.63k
SMAR.PSmartset Services Inc
$ 0.015
(-50.00%)
30k
ETUE2gold Inc
$ 0.005
(-50.00%)
101.7k
DDDMetavista3D Inc
$ 2.30
(-49.45%)
701.59k
MXL.HMX Gold Corp
$ 0.04
(-46.67%)
1.5k
NDANeptune Digital Assets Corp
$ 2.20
(30.18%)
5.15M
BRCBlackrock Silver Corp
$ 0.355
(-11.25%)
3.79M
TDGTDG Gold Corp
$ 0.45
(-1.10%)
3.19M
GPUSAlset AI Ventures Inc
$ 0.14
(-12.50%)
2.79M
PNGKraken Robotics Inc
$ 2.87
(0.35%)
2.69M

Discussion

View Full Feed
oldmystic oldmystic 51 seconds ago
I think it is very cool and like it, just not convinced of the value. In corporate life we spent a fair amount of effort on charting software and did extensive studies on TA to determine how much Alfa if any it can provide. The results were not overwhelming, which of course doesn't they can't be for
AVXL
TAB78 TAB78 1 minute ago
I have this a few times, I take it mean company wants us to know what the AS & OS is

I called OTC once and asked about why its updated daily on some, they said it depends on the arrangement between the company and their TA

Since the TA is the one that reports it to OTC
GRLF
Zorax Zorax 1 minute ago
We were already dealing with the highest assault of bird flu ever which was already raising prices.

And with rfk in the health spot, he'll not allow vaccines or studies and wait 5 years for everyone to get sick and die from bird flu because of his belief of a defunct and debunked deca
k9narc k9narc 1 minute ago
I prefer my kale

With a silent K
CanItBThisEZ2Make CanItBThisEZ2Make 2 minutes ago
Thank You, Very Much, That's a straight up $0.43 per share by rough calculations IMO - NFA!

GO $AZRH
AZRH
Invest-in-America Invest-in-America 2 minutes ago
TVGN: Is glorious Microsoft really proactively 'collaborating' with tiny TVGN ; or, is TVGN merely EXPLOITING Microsoft's already-existing AI services & products??? (Be very careful when a little-known company suddenly publishes so-called ' NEWS ' with terms like ' partnering with', or ' tea
TVGN
capgain capgain 2 minutes ago
Tele's and Lucinda, how can you go wrong? :)
KILLAZILLA KILLAZILLA 3 minutes ago
F- CREDIT RATING AND NO POSITIVE INCOME ARE 2 OTHERS....

SHOULD I LIST MORE???

MAMALUKE!!!
WDLF
declaes declaes 3 minutes ago
25,000,000 revenues in 2025!!!

style="font-size: 16px"Based on the prior year revenues in both Kentucky and West Palm Beach, Florida and the addition of the new beds in Boca Raton, Florida, the revenue target for all facilities in the Company for all of 2025 is $25,000,000.00.
GRST
wiwineguy wiwineguy 4 minutes ago
Looks great Mr Chen!  Thank you
TGLO
double_m double_m 4 minutes ago
Real funny when the dreamers show up on this board with posts showing optimism for $MULN. These guys refuse to believe any warnings about this company and its 💩CEO. Most of us have been dealing with Mullen for as much as 3 years and have lost varying amounts of money to the blatant lies and
MULN
ThunderousSeer8 ThunderousSeer8 4 minutes ago
It is tiring even for me seeing him exhausting himself in desperation
RDAR
justhefax justhefax 8 minutes ago
i share the desire for success as i do have a significant stake.
Apart from Schwab i don't see any visible sign of the name change. If any see other places good to know.

I dont see the work you refer to apart from releases going back to spring ( and Schwab). The name change was
KGKG
IhidfromtheX IhidfromtheX 8 minutes ago
Time diagnosed until the average life span for an illness IMO is a great marker...The longer the better...
AVXL
zab zab 9 minutes ago
I have noticed that also, did you see this article.

https://www.seattletimes.com/nation-world/nation/more-dei-fallout-air-force-scraps-course-that-used-videos-of-tuskegee-airmen-and-female-wwii-pilots/

https://www.detroitnews.com/story/news/politics/2025/01/25/air-force
exwannabe exwannabe 10 minutes ago
I think TVO gave end of February as a grace period for some time. Unlike many, he’s willing to say if it goes beyond that, his concern level would increase. Right now, he’s still expecting January (with February as the final grace period). IMO. I pretty much echo his sentiment, based upon his and ly
NWBO
Johnniegalan Johnniegalan 11 minutes ago
JR….tell that to the folks with special insight who have fueled a nearly 50% increase in the price of the stock in the last 3 weeks or so..
AMRN
boi568 boi568 12 minutes ago
If dramatic brain preservation is not a validated biomarker for AD because no other effective drug has achieved the most obviously desirable physical result for this disease, then the FDA should use whatever discretion it enjoys to relax the "validated" requirement here.

Otherwise, w
AVXL

Your Recent History

Delayed Upgrade Clock